Vol. 6 (04) pp. 781-791 DOI: 10.21474/IJAR01/6914

RECIPROCAL RELATIONSHIP BETWEEN INSULIN RESISTANCE AND DISTURBED ADMA/NO AXIS IN GESTATIONAL DIABETES MELLITUS.

, and
  • Department of Obstetrics & Gynecology, Faculty of Medicine, Tanta University, Egypt.
  • Department of Obstetrics & Gynecology, Faculty of Medicine, Benha University, Egypt.
  • Fellow & Researcher of Medical Biochemistry, Hospital Lab., Clinical Pathology department, Faculty of Medicine, Benha University.
9 Downloads 98 Views
Crossref

Download Full Paper (PDF)

Abstract

Objectives: To estimate serum nitric oxide (NO) and asymmetric dimethylarginine (ADMA) levels in pregnant women and correlate it with severity of gestational diabetes mellitus (GDM) judged by Oral Glucose Tolerance Test (OGTT). Patients & Methods: 225 pregnant women gave fasting blood samples to estimate baseline blood glucose (BG), and serum insulin, NO and ADMA, and to undergo OGTT. Insulin resistance (IR) was indicated by HOMA-IR score >2. At 24th week, blood sample were re-evaluated using OGTT and women were categorized in Study (GDM) and Control (free of GDM) group. Results: At 24th week, HOMA-IR scores were significantly higher than baseline scores and in study versus control women. Baseline serum ADMA levels were significantly higher, while serum NO levels were significantly lower in study versus control women and correlated with body mass index (BMI), GDM, BG and HOMA-IR score of all women. Serum ADMA and NO showed significant correlation with extent of serum insulin change, but low serum NO is significant predictor for development and severity of IR. Conclusion: IR induces endothelial dysfunction manifested as low serum NO and high serum ADMA. Baseline serum NO could predict the extent of serum insulin change.

Keywords

Article Analytics

References

  1. Lebovitz HE: Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001; 109 Suppl 2:S135-48.
  2. Cubbon RM, Kahn MB, Wheatcroft SB: Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond). 2009; 117(5):173-90.
  3. Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A: Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015; 19(1):160-4.
  4. Anaya HA, Yi FX, Boeldt DS, Krupp J, Grummer MA, Shah DM, Bird IM: Changes in Ca2+ Signaling and Nitric Oxide Output by Human Umbilical Vein Endothelium in Diabetic and Gestational Diabetic Pregnancies. Biol Reprod. 2015; 93(3):60.
  5. Baz B, Riveline JP, Gautier JF: Endocrinology of pregnancy: Gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol.?2016; 174(2):R43-51.
  6. Retnakaran R, Ye C, Kramer CK, Connelly PW, Hanley AJ, Sermer M, Zinman B: Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes. J Clin Endocrinol Metab. 2016; 101(7):2683-91.
  7. Silva-Zolezzi I, Samuel TM, Spieldenner J: Maternal nutrition: opportunities in the prevention of gestational diabetes. Nutr Rev. 2017; 75(suppl 1):32-50.
  8. Qvigstad E: The diversity of gestational diabetes - a therapeutic challenge. Eur J Endocrinol. 2018 Jan 16. pii: EJE-18-0012.
  9. Eades CE, France EF, Evans JMM: Postnatal experiences, knowledge and perceptions of women with gestational diabetes. Diabet Med. 2018 Jan 16. doi: 10.1111/dme.13580.
  10. Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, Keerthy D, Jolly K, Saravanan P, Nirantharakumar K: Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study. PLoS Med. 2018 Jan 16; 15(1):e1002488.
  11. Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, Cottin Y, Vergely C: Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther. 2013; 140(3):239-57.
  12. Tousoulis D, Georgakis MK, Oikonomou E, Papageorgiou N, Zaromitidou M, Latsios G, Papaioannou S, Siasos G: Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches. Curr Med Chem. 2015; 22(24):2871-901.
  13. Davids M, Teerlink T: Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells. Metabolism. 2013; 62(10):1455-61.
  14. Al-Kholy AF, Hassan M, Serag MM, Abou Ragab HM: Nitric oxide/Asymmetric Dimethylarginine axis may interplay with sex hormones for pathogenesis and severity of Pre-eclampsia: Study controlled by Uterine Arterial Doppler. Bull. Egypt. Soc. Physiol. Sci., 37(1): 80-91.
  15. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization, 1995.
  16. American Diabetes Association, Diabetes Care, 2004; 27(Suppl. 1), S5?S10.
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia.1985; 28:412?19.
  18. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care.?2013; 36 Suppl 1:S67-74
  19. Lowe LP, Metzger BE,?Dyer AR, Lowe J, McCance DR, Lappin TR, Trimble ER, Coustan DR, Hadden DR, Hod M, Oats JJ, Persson B, the HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care?2012 Mar;?35(3):?574-80.
  20. International association of diabetes and pregnancy study groups (IADPSG) recommendations on the diagnosis and classification of hyperglycemia in pregnancy.?Diabetes Care.?2010; 33:676?682.
  21. Tinder P: Determination of blood glucose. Ann. Clin. Biochem.; 6:24, 1969.
  22. Makin HLJ, Gower DB: Analysis of vitamin D. Their Metabolites and Analogues, In: Steroid analysis. Springer, London, 2010; chapter 11, 967-1096.
  23. Bredt DS, Snyder SH: Nitric oxide: A physiologic messenger molecule. Annu. Rev. Biochem. 1994; 63, 175?95.
  24. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, B?ger RH: Determination of ADMA using a novel ELISA assay. Clin. Chem. Lab. Med. 2004; 42: 1377-83.
  25. Giacobbe A, Granese R, Grasso R, Salpietro V, Corrado F, Giorgianni G, Foti G, Amadore D, Triolo O, Giunta L, Di Benedetto A: Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus. Nutr Metab Cardiovasc Dis. 2016; 26(5):414-8.
  26. Silva L, Subiabre M, Araos J, Salsoso R, Fuenzalida B, S?ez T, Toledo F, Gonz?lez M, Quezada C, Pardo F, Chiarello DI, Leiva A, Sobrevia L: Akt/mTOR Role in human foetoplacental vascular insulin resistance in diseases of pregnancy. J Diabetes Res. 2017; 2017. Epub 2017 Sep 14 doi:10.1155/2017/5947859
  27. Tsiotra PC, Halvatsiotis P, Patsouras K, Maratou E, Salamalekis G, Raptis SA, Dimitriadis G, Boutati E: Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Peptides. 2018 Jan 11. pii: S0196-9781(18)30011-1. doi: 10.1016/j.peptides.2018.01.005.
  28. Hill DJ: Placental control of metabolic adaptations in the mother for an optimal pregnancy outcome. What goes wrong in gestational diabetes? Placenta. 2018 Jan 9. pii: S0143-4004(18)30004-3
  29. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, Lowe LP, Coustan DR, Hod M, Oats JJ, Persson B, Trimble ER; HAPO Study Cooperative Research Group: Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012; 35(3):526-8.
  30. Waters TP, Dyer AR, Scholtens DM, Dooley SL, Herer E, Lowe LP, Oats JJ, Persson B, Sacks DA, Metzger BE, Catalano PM; HAPO Cooperative Study Research Group: Maternal and Neonatal Morbidity for Women Who Would Be Added to the Diagnosis of GDM Using IADPSG Criteria: A Secondary Analysis of the Hyperglycemia and Adverse Pregnancy Outcome Study. Diabetes Care. 2016; 39(12):2204-10.
  31. Lacaria E, Lencioni C, Russo L, Romano M, Lemmi P, Battini L, Del Prato S, Bertolotto A, Di Cianni G: Selective screening for GDM in Italy: application and effectiveness of National Guidelines. See comment in PubMed Commons belowJ Matern Fetal Neonatal Med. 2015;28(15):1842-4.
  32. DU HY, Jiang H, O K, Chen B, Xu LJ, Liu SP, Yi JP, He GS, Qian X: Association of Dietary Pattern during Pregnancy and Gestational Diabetes Mellitus: A Prospective Cohort Study in Northern China. Biomed Environ Sci. 2017; 30(12):887-97.
  33. Wang X, Li W, Ma L, Ping F, Liu J, Wu X, Mao J, Wang X, Nie M: MiRNA-binding site variants of type 2 diabetes candidate loci predispose to gestational diabetes mellitus in Chinese Han women. J Diabetes 2018 Jan 20. doi: 10.1111/jdi.12803
  34. Pan SC, Huang CC, Lin SJ, Chen BY, Chang CC, Leon Guo YL: Gestational diabetes mellitus was related to ambient air pollutant nitric oxide during early gestation. Environ Res. 2017;158:318-323.
  35. Zambon M, Mand? C, Lissoni A, Anelli GM, Novielli C, Cardellicchio M, Leone R, Monari MN, Massari M, Cetin I, Abati S: Inflammatory and Oxidative Responses in Pregnancies With Obesity and Periodontal Disease. Reprod Sci. 2018 Jan 1:1933719117749758.
  36. Lindsay KL, Brennan L, Kennelly MA, Curran S, Coffey M, Smith TP, Foley ME, Hatunic M, McAuliffe FM: Maternal metabolic response to dietary treatment for impaired glucose tolerance and gestational diabetes mellitus. Ir J Med Sci. 2018 Jan 20. doi: 10.1007/s11845-018-1744-y
  37. Atay AE, Akbas H, Tumer C, Sakar MN, Esen B, Incebiyik A, Simsek S, Sit D: The association of endothelial nitric oxide synthase gene G894T polymorphism and serum nitric oxide concentration with microalbuminuria in patients with gestational diabetes. Clin Nephrol. 2014; 81(2):105-11.
  38. Atay AE, Simsek H, Demir B, Sakar MN, Kaya M, Pasa S, Demir S, Sit D: Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes. Herz. 2014; 39(5):627-32
  39. Gumus II, Kargili A, Kaygusuz I, Derbent A, Karakurt F, Kasapoglu B, Uysal S: The association between serum asymmetric dimethyl arginine levels and a history of gestational diabetes among healthy women. Blood Coagul Fibrinolysis. 2012; 23(5):391-5.
  40. Xia W, Li D, Zhang C, Xu L, Xu W, Shao Y: Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus. 2015; 48(2):528-32
  41. Pleiner J, Mittermayer F, Langenberger H, Winzer C, Schaller G, Pacini G, Kautzky-Willer A, Tura A, Wolzt M: Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes. Wien Klin Wochenschr. 2007; 119(15-16):483-9.
  42. Sertkaya AC,?Kafkasli A,?Turkcuoglu I,?Karabulut AB: Asymmetric dimethylarginine level in hyperglycemic gestation. Endocrine.?2011; 40(2):237-42.
  43. Sciacqua A,?Grillo N,?Quero M,?Sesti G,?Perticone F: Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients. Int J Mol Sci.?2012 Oct 24;13(11):13804-15
  44. Kashiwagi S, Atochin DN, Li Q, Schleicher M, Pong T, Sessa WC, Huang PL: eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun. 2013; 431(2):284-90.
  45. Manrique C, Lastra G, Sowers JR: New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci. 2014; 1311:138-50.
  46. Muniyappa R, Sowers JR: Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013; 14(1):5-12.
  47. Strisciuglio T, De Luca S, Capuano E, Luciano R, Niglio T, Trimarco B, Galasso G: Endothelial dysfunction: its clinical value and methods of assessment. Curr Atheroscler Rep. 2014; 16(6):417
  48. El Assar M, Angulo J, Santos-Ruiz M, Ruiz de Adana JC, Pindado ML, S?nchez-Ferrer A, Hern?ndez A, Rodr?guez-Ma?as L: Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. J Physiol. 2016; 594(11):3045-60.

How to Cite This Article

Ahmed M Hagras, Hesham M Abo Ragab and Raafat R. Mohammed. (2018); RECIPROCAL RELATIONSHIP BETWEEN INSULIN RESISTANCE AND DISTURBED ADMA/NO AXIS IN GESTATIONAL DIABETES MELLITUS., Int. J. of Adv. Res., 6 (04), 781-791, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6914

Corresponding Author

Hesham M Abo Ragab
Department of Obstetrics & Gynecology, Faculty of Medicine, Benha University, Egypt.
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.